Health-related quality of life among people who inject drugs in Australia.

"Declarations Conflict of interestGD has received research grants from AbbVie, Gilead Sciences and Merck. JG is a consultant/advisor and has received research grants from AbbVie, Camurus, Cepheid, Gilead Sciences, Hologic, Indivior and Merck. Ethical approvalThe study protocol and amendments were approved by the Human Research Ethics Committee at St. Vincent's Hospital, Sydney (HREC/12/SVH/34). Conflict of interest GD has received research grants from AbbVie, Gilead Sciences and Merck. JG is a consultant/advisor and has received research grants from AbbVie, Camurus, Cepheid, Gilead Sciences, Hologic, Indivior and Merck."

"Funding Open Access funding enabled and organized by CAUL and its Member Institutions. This work was supported by funding from the National Health and Medical Research Council (NHMRC) (1103165), Merck Sharp & Dohme, Australia, Cepheid and South Eastern Sydney Local Health District. The Kirby Institute is funded by the Australian Government Department of Health and Ageing. The views expressed in this publication do not necessarily represent the position of the Australian Government."